None

NanoBio CEO leaves to head Merck vaccine franchise

NanoBio Corp. (Ann Arbor, Mich.) said founder and CEO James Baker left to join Merck & Co. Inc. (NYSE:MRK) as SVP, head global vaccine franchise. NanoBio promoted David Peralta to CEO from COO and CFO...

Editorial: Nanobio versus Bionano – what's in a name?

Nanobio versus Bionano – what's in a name?This special Issue of Biotechnology Journal includes two sections, one featuring articles on nanobio, the other articles on bionano. The editors of the issu...

NanoBio-Europe conference to take place from June 18-20 in Varese

The 8th NanoBio-Europe conference will take place on 18 - 20 June 2012 in Varese (Lombardy, Northern Italy), showcasing the latest international developments in nanobiotechnology, and providing a plat...

So Close They Can Taste It; NanoBio, Investors Eye Potential IPO

Is NanoBio heading towards an IPO? Probably way too early to make that call. But the Ann Arbor, MI-based drug startup and its investors are not exactly discouraging such talk. “I think the compa...

NanoBio Announces Data Presentation on its Nanoemulsion Adjuvanted RSV Vaccine at IDWeek 2012

ANN ARBOR, Mich. & SAN DIEGO--(BUSINESS WIRE)--Oct 15, 2012 - NanoBio® Corporation announced today that results from its nanoemulsion adjuvanted RSV vaccine will be presented at IDWeek 2012&...

NanoBio to Present Preclinical Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine and Novel Inhaled Cystic Fibrosis Therapy at 52nd Annual ICAAC Meeting

ANN ARBOR, Mich.--(BUSINESS WIRE)--September 10, 2012 10:48 AM Eastern Daylight Time--NanoBio® Corporation announced today it will present data from two separate preclinical studies at the 52nd In...

NanoBio to Report Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium

ANN ARBOR, Mich. & SANTA FE, N.M.--(BUSINESS WIRE)--Sep 24, 2012 - NanoBio® Corporation announced today it will present data from three preclinical studies at the 8th Annual International Re...

Series C from returning shareholders brings $11mm to [NanoBio]

[NanoBio Corp.] (vaccines, dermatological agents, and anti-infectives) has raised $11mm in its Series C financing from all returning shareholders including Perseus LLC and Venture Investors. Funds wil...

Nanobio Silver: Its Interactions with Peptides and Bacteria, and Its Uses in Medicine.

Long-term real-time tracking of lanthanide ion doped upconverting nanoparticles in living cells.

Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy.

Enhanced charge injection in pentacene field-effect transistors with graphene electrodes.

Radical Polymer-Wrapped SWNTs at a Molecular Level: High-Rate Redox Mediation Through a Percolation Network for a Transparent Charge-Storage Material.